Posttransplant lymphoproliferative disease.
Soltys
Kyle
K
Starzl Transplant Institute and the Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Green
Michael
M
D019264:Adoptive Transfer; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D000998:Antiviral Agents / Q000627:therapeutic use; D020031:Epstein-Barr Virus Infections / Q000150:complications* / Q000276:immunology; D004854:Herpesvirus 4, Human; D006801:Humans; D008232:Lymphoproliferative Disorders / Q000188:drug therapy / Q000276:immunology / Q000517:prevention & control; D016377:Organ Transplantation / Q000009:adverse effects*; D012307:Risk Factors; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000998:Antiviral Agents; D000069283:Rituximab